Geneseeq
Business Services · China · 201-500 Employees
View Company Info for Free
Overview
Headquarters
Floor 18 Building B Sino Danish Life Sci...Phone Number
(800) 362-0325Website
www.geneseeq.comRevenue
$47.3 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Geneseeq
Geneseeq Technology Inc. is a leading Precision Oncology Company that specializes in advanced NGS-based solutions for cancer diagnosis, prognosis, treatment guidance, and drug development. Their comprehensive services empower oncologists, researchers, and patients with actionable genomic insights across various cancer types, including solid tumors and hematologic malignancies. The company offers a wide range of products and services, including central lab testing, local testing solutions, and customized research services, all aimed at accelerating precision cancer care. With a strong focus on quality and efficiency, Geneseeq collaborates with biopharma and research partners to provide high-quality genomic data and support translational research.Explore more
Popular SearchesGeneseeqGeneSeeq Technology IncGeneseer IncGeneseeq Tech IncGeneseeq Technology Inc | A Precision Oncology CoSIC Code 87,873NAICS Code 54,541Show moreGeneseeq Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Geneseeq your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Geneseeq is spiking on competitors!
Click to see if Geneseeq had a recent Job posting/layoffs
Check if Geneseeq has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at Geneseeq
Funding: Get notified immidiatlly once Geneseeq has new funding data
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Geneseeq recently announced quarterly report
Geneseeq, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Geneseeq launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Find VP level buyers at Geneseeq
Find 3 more new buyers
Company Profile Activity
Activity Insights
Geneseeq is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Geneseeq is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Geneseeq.
Geneseeq financials insights
Gather financial insights about Geneseeq, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2014
Series A
$4.8M
2016
Series B
$9.1M
2019
Series D
$114M
Geneseeq Tech Stack
A closer look at the technologies used by Geneseeq
See more technologies
Most Recent Scoops
Person-Based
Person-Based
Person-Based
Event
Events
Facilities Relocation / Expansion
Facilities Relocation/Expansion
Geneseeq News & Media
GeneseeqPrime® Gains FDA 510(k) Clearance
With FDA., CE-IVD, and NMPA approvals, the comprehensive tumor profiling kit enables decentralized, standardized oncology testing worldwide TORONTO, Sept. 2, 2025 /PRNewswire/ - Geneseeq Technology Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k)...Geneseeq's Breakthrough Cancer Detection Blood Test Published in Nature Medicine
Large-Scale Study Confirms CanScan® Test Accurately Detects Early-Stage Cancers From a Simple Blood Draw TORONTO, May 28, 2025 /PRNewswire/ - Geneseeq is proud to announce the publication of results from its large-scale multi-cancer early detection (MCED) study in Nature Medicine, one of...Geneseeq Unveils Groundbreaking Blood Test for Early Detection of Pancreatic Cancer
TORONTO, May 7, 2025 /PRNewswire/ - Geneseeq Technology Inc., in collaboration with leading clinical institutions, has developed a cutting-edge blood-based screening test that could transform early detection of pancreatic cancer-potentially saving by identifying the disease at more...FDA Grants Breakthrough Device Designation for Geneseeq's Multi-cancer Early Detection Solution
TORONTO, Jan. 3, 2024 /PRNewswire/ - Geneseeq announced that its multi-cancer early detection solution, CanScan™, has been granted Breakthrough Device Designation by the US Food and Drug Administration (FDA). CanScan™ utilizes low-depth whole-genome sequencing (WGS) on circulating...
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Geneseeq
Sign Up For FreeTo access detailed company insights
Geneseeq Technology Inc. is a leading Precision Oncology Company that specializes in advanced NGS-based solutions for cancer diagnosis, prognosis, treatment guidance, and drug development. Their comprehensive services empower oncologists, researchers, and patients with actionable genomic insights across various cancer types, including solid tumors... Read More
